Variant report

Variant	esv3385040
Chromosome Location	chr5:79330296-79332294
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:26)
CpG islands
(count:610)
Chromatin interactive
region (count:1)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:26 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr5:79330830-79331030	H1-hESC	embryonic stem cell:	n/a	n/a
2	GABPA	chr5:79331120-79331398	H1-hESC	embryonic stem cell:	n/a	n/a
3	GTF2F1	chr5:79330455-79330623	H1-hESC	embryonic stem cell:	n/a	n/a
4	HMGN3	chr5:79331220-79331420	K562	blood:	n/a	n/a
5	JUN	chr5:79330860-79330920	H1-hESC	embryonic stem cell:	n/a	n/a
6	JUND	chr5:79330896-79331034	H1-hESC	embryonic stem cell:	n/a	n/a
7	JUND	chr5:79331107-79331308	H1-hESC	embryonic stem cell:	n/a	n/a
8	JUND	chr5:79331314-79331448	H1-hESC	embryonic stem cell:	n/a	n/a
9	POLR2A	chr5:79331376-79331401	H1-hESC	embryonic stem cell:	n/a	n/a
10	POLR2A	chr5:79331109-79331367	H1-hESC	embryonic stem cell:	n/a	n/a
11	POLR2A	chr5:79331111-79331355	H1-hESC	embryonic stem cell:	n/a	n/a
12	POLR2A	chr5:79331046-79331087	H1-hESC	embryonic stem cell:	n/a	n/a
13	POLR2A	chr5:79330875-79331069	H1-hESC	embryonic stem cell:	n/a	n/a
14	POLR2A	chr5:79331489-79331513	H1-hESC	embryonic stem cell:	n/a	n/a
15	RAD21	chr5:79331193-79331552	H1-hESC	embryonic stem cell:	n/a	n/a
16	RAD21	chr5:79330891-79331003	H1-hESC	embryonic stem cell:	n/a	n/a
17	SIN3A	chr5:79330709-79331446	H1-hESC	embryonic stem cell:	n/a	chr5:79331146-79331157
18	TAF1	chr5:79331071-79331558	H1-hESC	embryonic stem cell:	n/a	n/a
19	TAF1	chr5:79331130-79331401	H1-hESC	embryonic stem cell:	n/a	n/a
20	TBP	chr5:79331243-79331813	H1-hESC	embryonic stem cell:	n/a	n/a
21	TBP	chr5:79330829-79330986	H1-hESC	embryonic stem cell:	n/a	n/a
22	TCF12	chr5:79331272-79331511	H1-hESC	embryonic stem cell:	n/a	n/a
23	YY1	chr5:79331083-79331379	H1-hESC	embryonic stem cell:	n/a	chr5:79331152-79331163
24	YY1	chr5:79331659-79332259	H1-hESC	embryonic stem cell:	n/a	chr5:79332055-79332067
25	YY1	chr5:79331859-79332194	H1-hESC	embryonic stem cell:	n/a	chr5:79332055-79332067
26	ZNF143	chr5:79330761-79331391	H1-hESC	embryonic stem cell:	n/a	n/a

(count:610 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:79330669-79330719	HPAEpiC	pulmonary alveolar:	n/a
2	chr5:79330259-79330309	NB4	blood:	n/a
3	chr5:79331477-79331527	HCT-116	colon:	n/a
4	chr5:79331850-79331900	HEEpiC	esophagus:	n/a
5	chr5:79331850-79331900	GM12892	blood:	n/a
6	chr5:79330259-79330309	HepG2	liver:	n/a
7	chr5:79331047-79331097	GM12892	blood:	n/a
8	chr5:79331477-79331527	NB4	blood:	n/a
9	chr5:79331047-79331097	SK-N-SH	brain:	n/a
10	chr5:79330799-79330849	AG10803	skin:	n/a
11	chr5:79330959-79331009	U87	brain:	n/a
12	chr5:79330943-79330993	HL-60	blood:	n/a
13	chr5:79330259-79330309	MCF-7	breast:	n/a
14	chr5:79331850-79331900	GM12878	blood:	n/a
15	chr5:79330959-79331009	Hepatocyte	liver:	n/a
16	chr5:79331477-79331527	H1-hESC	embryonic stem cell:	embryo
17	chr5:79330259-79330309	A549	lung:	n/a
18	chr5:79331047-79331097	Caco-2	colon:	n/a
19	chr5:79330943-79330993	AG04450	lung:	fetal
20	chr5:79330959-79331009	T-47D	breast:	n/a
21	chr5:79330943-79330993	LNCaP	prostate:	n/a
22	chr5:79331850-79331900	H1-hESC	embryonic stem cell:	embryo
23	chr5:79330943-79330993	HAEpiC	amniotic membrane:	n/a
24	chr5:79331047-79331097	Jurkat	blood:	n/a
25	chr5:79330959-79331009	RPTEC	kidney:	n/a
26	chr5:79331477-79331527	MCF10A-Er-Src	breast:	n/a
27	chr5:79330929-79330979	HIPEpiC	eye:	n/a
28	chr5:79331047-79331097	NHDF-neo	bronchial:	n/a
29	chr5:79330943-79330993	MCF10A-Er-Src	breast:	n/a
30	chr5:79331135-79331185	PFSK-1	brain:	n/a
31	chr5:79331477-79331527	SK-N-MC	brain:	n/a
32	chr5:79331477-79331527	GM06990	blood:	n/a
33	chr5:79330669-79330719	GM12878	blood:	n/a
34	chr5:79331047-79331097	Hepatocyte	liver:	n/a
35	chr5:79330259-79330309	AG04450	lung:	fetal
36	chr5:79330943-79330993	ProgFib	skin:	n/a
37	chr5:79331477-79331527	AoSMC	blood vessel:	n/a
38	chr5:79331850-79331900	PrEC	prostate:	n/a
39	chr5:79331047-79331097	PrEC	prostate:	n/a
40	chr5:79330929-79330979	PFSK-1	brain:	n/a
41	chr5:79330929-79330979	SAEC	small airway:	n/a
42	chr5:79330943-79330993	AG09319	gingival:	n/a
43	chr5:79330929-79330979	Caco-2	colon:	n/a
44	chr5:79330799-79330849	NHBE	bronchial:	n/a
45	chr5:79331477-79331527	IMR90	lung:	fetal
46	chr5:79330959-79331009	MCF10A-Er-Src	breast:	n/a
47	chr5:79330669-79330719	CMK	blood:	n/a
48	chr5:79330929-79330979	HL-60	blood:	n/a
49	chr5:79330799-79330849	HL-60	blood:	n/a
50	chr5:79330929-79330979	AG10803	skin:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr5:79332099..79334519-chr5:79339709..79341668,2	K562	blood:

No data

Variant related genes	Relation type
TRMT112P2	TF binding region
THBS4	TF binding region
TRMT112P2	CpG island
THBS4	CpG island

Extended variants
information (count: 69 )
Associated
traits (count: 79 )

Variant overlapped rSNPs/rCNVs (count:69 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs74562796	chr5:79330305-79330306	Bivalent/Poised TSS Bivalent Enhancer	CpG island	2 gene(s)	Overlapped CNVs	n/a
2	rs75768345	chr5:79330344-79330345	Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs189554010	chr5:79330368-79330369	Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs146977120	chr5:79330388-79330389	Bivalent/Poised TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs538758842	chr5:79330446-79330447	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs551660006	chr5:79330451-79330452	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs80314315	chr5:79330459-79330460	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
8	rs76616753	chr5:79330461-79330462	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
9	rs571250866	chr5:79330483-79330484	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
10	rs192030180	chr5:79330493-79330494	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
11	rs555219794	chr5:79330528-79330529	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
12	rs537727994	chr5:79330551-79330552	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
13	rs557695713	chr5:79330555-79330556	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
14	rs3813667	chr5:79330559-79330560	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs184581143	chr5:79330590-79330591	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
16	rs147653575	chr5:79330597-79330598	Flanking Bivalent TSS/Enh Bivalent/Poised TSS Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
17	rs149109223	chr5:79330601-79330602	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
18	rs545532382	chr5:79330625-79330626	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs188500699	chr5:79330632-79330633	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs575106958	chr5:79330649-79330650	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs544057553	chr5:79330681-79330682	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	CpG island	2 gene(s)	Overlapped CNVs	n/a
22	rs560873901	chr5:79330729-79330730	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
23	rs529659656	chr5:79330749-79330750	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
24	rs556558520	chr5:79330773-79330774	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
25	rs546264750	chr5:79330777-79330778	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
26	rs201719643	chr5:79330783-79330784	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
27	rs181275768	chr5:79330799-79330800	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
28	rs560120285	chr5:79330801-79330802	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
29	rs143032034	chr5:79330819-79330820	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
30	rs186701255	chr5:79330833-79330834	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
31	rs114963482	chr5:79330845-79330846	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
32	rs189079096	chr5:79330859-79330860	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
33	rs551267378	chr5:79330944-79330945	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
34	rs567975180	chr5:79330945-79330946	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
35	rs536980982	chr5:79331071-79331072	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
36	rs553090896	chr5:79331147-79331148	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
37	rs4425490	chr5:79331194-79331195	Bivalent/Poised TSS Bivalent Enhancer Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
38	rs538718070	chr5:79331229-79331230	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
39	rs558632577	chr5:79331260-79331261	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
40	rs17878424	chr5:79331264-79331265	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
41	rs544018935	chr5:79331291-79331292	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
42	rs554380164	chr5:79331328-79331329	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
43	rs3749684	chr5:79331438-79331439	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs540565168	chr5:79331495-79331496	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region CpG island	2 gene(s)	Overlapped CNVs	n/a
45	rs148180881	chr5:79331537-79331538	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	Overlapped CNVs	n/a
46	rs17886956	chr5:79331538-79331539	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Enhancers	TF binding region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
47	rs190923205	chr5:79331642-79331643	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
48	rs562592070	chr5:79331650-79331651	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
49	rs541403998	chr5:79331673-79331674	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a
50	rs531091682	chr5:79331712-79331713	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Enhancers Flanking Active TSS	TF binding region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:79)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	22032731	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Prostate cancer	21965145	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	19602461	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Merkel cell carcinoma	19020549	CNVD
Squamous cell cancer	20885788	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ovarian cancer	21720365	CNVD
Acute myeloid leukemia	21251322	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Myelofibrosis	22110671	CNVD
craniofacial dysmorphism	21918468	CNVD
lymphocytic leukemia	21291569	CNVD
Lung cancer	16773561	CNVD
Multiple myeloma	16616336	CNVD
Testicular cancer	18059402	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16573809	CNVD

Chromatin state (count:190 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:79330000-79330400	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
2	chr5:79330000-79330600	Bivalent Enhancer	Fetal Kidney	kidney
3	chr5:79330200-79330600	Bivalent Enhancer	Fetal Muscle Leg	muscle
4	chr5:79330200-79332200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
5	chr5:79330400-79330600	Flanking Bivalent TSS/Enh	ES-I3 Cell Line	embryonic stem cell
6	chr5:79330400-79330600	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
7	chr5:79330400-79330600	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
8	chr5:79330400-79330600	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
9	chr5:79330400-79330600	Bivalent/Poised TSS	Cortex derived primary cultured neurospheres	brain
10	chr5:79330400-79330800	Active TSS	Ovary	ovary
11	chr5:79330400-79331400	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
12	chr5:79330400-79331600	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
13	chr5:79330400-79331600	Active TSS	Ganglion Eminence derived primary cultured neurospheres	brain
14	chr5:79330400-79332000	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
15	chr5:79330400-79332200	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
16	chr5:79330600-79330800	Bivalent/Poised TSS	iPS DF 19.11 Cell Line	embryonic stem cell
17	chr5:79330600-79330800	Bivalent/Poised TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
18	chr5:79330600-79330800	Flanking Bivalent TSS/Enh	ES-UCSF4 Cell Line	embryonic stem cell
19	chr5:79330600-79330800	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
20	chr5:79330600-79330800	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
21	chr5:79330600-79330800	Bivalent Enhancer	Primary T killer naive cells fromperipheralblood	blood
22	chr5:79330600-79330800	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
23	chr5:79330600-79330800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
24	chr5:79330600-79330800	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
25	chr5:79330600-79330800	Bivalent Enhancer	Liver	Liver
26	chr5:79330600-79330800	Flanking Bivalent TSS/Enh	Duodenum Smooth Muscle	Duodenum
27	chr5:79330600-79330800	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
28	chr5:79330600-79330800	Flanking Bivalent TSS/Enh	Fetal Kidney	kidney
29	chr5:79330600-79330800	Bivalent/Poised TSS	Skeletal Muscle Male	skeletal muscle
30	chr5:79330600-79330800	Bivalent Enhancer	Thymus	Thymus
31	chr5:79330600-79331000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells	blood
32	chr5:79330600-79331000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
33	chr5:79330600-79331000	Flanking Bivalent TSS/Enh	Cortex derived primary cultured neurospheres	brain
34	chr5:79330600-79331000	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin03	Skin
35	chr5:79330600-79331000	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
36	chr5:79330600-79331000	Bivalent/Poised TSS	NHEK	skin
37	chr5:79330600-79331200	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
38	chr5:79330600-79331200	Bivalent/Poised TSS	Psoas Muscle	Psoas
39	chr5:79330600-79331200	Bivalent/Poised TSS	Right Ventricle	heart
40	chr5:79330600-79331400	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin01	Skin
41	chr5:79330600-79331400	Bivalent/Poised TSS	Foreskin Fibroblast Primary Cells skin02	Skin
42	chr5:79330600-79331400	Bivalent/Poised TSS	Fetal Brain Female	brain
43	chr5:79330600-79331600	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
44	chr5:79330600-79331600	Bivalent Enhancer	Primary neutrophils fromperipheralblood	blood
45	chr5:79330600-79331600	Bivalent/Poised TSS	Primary T cells from cord blood	blood
46	chr5:79330600-79331600	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
47	chr5:79330600-79331600	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
48	chr5:79330600-79331600	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
49	chr5:79330600-79331600	Active TSS	Brain Anterior Caudate	brain
50	chr5:79330600-79331600	Bivalent Enhancer	Fetal Intestine Small	intestine

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links